PD is well know to affect movement, producing motor symptoms, and also to cause non-motor symptoms, which include autonomic dysfunction, neuropsychiatric problems (mood, cognition, behavior or thought alterations, personality changes, etc.), and sensory and sleep difficulties
Anti-obesity pharmacological agents for polycystic ovary syndrome: a systematic review and meta-analysis to inform the 2023 international evidence-based guideline
PlexusDx's Precision Peptide Genetic Test examines variants in the FTO, GLP1R, GIPR, and MC4R genesmarkers that influence how your body processes appetite signals, glucose regulation, and satiety
Research aims to determine whether GLP-3 causes similar GI side effects as GLP-1, if tolerability differs between the peptides, what optimal dosing strategies minimize side effects, and if GLP-3 might suit patients who dont tolerate GLP-1 agonists well